Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Rogaine

This article was originally published in The Tan Sheet

Executive Summary

Rogaine: Pharmacia & Upjohn sponsoring International Hockey League overtime tie-breaker shootouts, the "Rogaine Hair-Raising Finish," with the first one at the Feb. 17 IHL All-Star Game in Grand Rapids, Mich. That game also featured the Rogaine IHL All-Star Skills Challenge, including a "breakaway relay" to feature the "best players of the Eastern and Western Conferences of the IHL." The league will select a "Rogaine Comeback Player of the Year" as part of the promotion. During the IHL playoffs, the "Hair-Raising Finish" name also will be announced for non-"shootout" overtime periods. During the current season, P&U notes, more than 100 league games have ended with tie-breakers...

Rogaine: Pharmacia & Upjohn sponsoring International Hockey League overtime tie-breaker shootouts, the "Rogaine Hair-Raising Finish," with the first one at the Feb. 17 IHL All-Star Game in Grand Rapids, Mich. That game also featured the Rogaine IHL All-Star Skills Challenge, including a "breakaway relay" to feature the "best players of the Eastern and Western Conferences of the IHL." The league will select a "Rogaine Comeback Player of the Year" as part of the promotion. During the IHL playoffs, the "Hair-Raising Finish" name also will be announced for non-"shootout" overtime periods. During the current season, P&U notes, more than 100 league games have ended with tie-breakers....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS086730

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel